Stockreport

Stock Market Today, April 16: Hims & Hers Health Jumps on FDA Review of Compounded Peptide Therapies [Globe and Mail, The (Toronto, Canada)]

Teladoc Health, Inc.  (TDOC) 
Last teladoc health, inc. earnings: 4/29 04:05 pm Check Earnings Report
US:NYSE Investor Relations: ir.teladoc.com/investors/default.aspx
PDF at $26.98, up 11.07%. The stock moved higher as investors reacted to the FDA's decision to review compounded peptide therapies. Trading volume reached 74.6 million share [Read more]